Australia's largest stock trading and investment forum Australia's #1 stock forum

IXC

Click for more information

0.00%

7.0¢ invex therapeutics ltd

Yes, my statement mentioning that “…we will aim to obtain ODD in...

First 11 Last

Share
Profile

Follow
DTrader93

180 Posts.

25

10/07/23

14:46

Post #: 68709373
Share

Originally posted by jellyroll: ↑

"The Company has filed an additional ODD for the US Market for moderate to severe TBI, which if
granted in 2H CY2023 will provide seven years market exclusivity for Exenatide, certain tax credits
and a waiver from the Prescription Drug User Fee Act (PDUFA) fees, which were approximately
US$3.1 million in 2022. A proof of concept clinical trial for Exenatide to lower ICP in moderate to
severe TBI is under consideration."

This seems to be the key part from the 4C comments.

Expand

Yes, my statement mentioning that “…we will aim to obtain ODD in the US…” is based on it not being a guarantee that we will obtain it.

IXC Price at posting: 19.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 19 more messages in this thread...

First 11 Last

Add IXC (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change 0.000(0.00%)		Mkt cap ! $5.261M

Open	High	Low	Value	Volume
7.0¢	7.0¢	7.0¢	$3.435K	49.06K

Buyers (Bids)

No.	Vol.	Price($)
1	932	7.0¢

Sellers (Offers)

Price($)	Vol.	No.
7.2¢	26920	1

View Market Depth

No.	Vol.	Price($)
1	932	0.070
1	10000	0.051
1	200000	0.050
1	60001	0.043
2	510000	0.040

Price($)	Vol.	No.
0.072	26920	1
0.077	7950	1
0.078	52542	1
0.080	30000	2
0.081	888	1

Last trade - 15.40pm 13/06/2024 (20 minute delay)

IXC (ASX) Chart